Literature DB >> 23088887

Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity.

Yixin Chen1, Chuan Li, Delei He, Tong Cheng, Shengxiang Ge, James Wai-Kuo Shih, Qinjian Zhao, Pei-Jer Chen, Jun Zhang, Ningshao Xia.   

Abstract

In recent year, Enterovirus 71 (EV71)-associated hand, foot and mouth disease (HFMD) has become an important public health issue in China. EV71 has been classified into genotypes A, B1-B5 and C1-C5. With such genetic diversity, whether the convalescent or recovery antibody responses can cross-protect infections from other genotypes remains a question. Understanding of the antigenicity of such diverse genetic EV71 isolates is crucial for the EV71 vaccine development. Here, a total of 186 clones anti-EV71 MAbs was generated and characterized with Western blot and cell-based neutralization assay. Forty neutralizing anti-EV71 MAbs were further used to analyze the antigenic properties of 18 recent EV71 isolates representing seven genotypes in neutralization assay. We found that most neutralizing anti-EV71 MAbs are specific to conformational epitopes. We also classified the 40 neutralizing anti-EV71 MAbs into two classes according to their reactivity patterns with 18 EV71 isolates. Class I MAb can neutralize all isolates, suggesting conserved epitopes are present among EV71. Class II MAb includes four subclasses (IIa-IId) and neutralizes only subgroups of EV71 strains. Conversely, 18 EV71 strains were grouped into antigenic types 1 and four antigenic subtypes (2.1-2.4). These results suggest that the current genotyping of EV71 does not reflect their antigenicity which may be important in the selection of EV71 vaccine strains. This panel of neutralizing anti-EV71 MAbs may be useful for the recognition of emerging antigenic variants of EV71 and vaccine development.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23088887     DOI: 10.1016/j.vaccine.2012.10.032

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

1.  Development of an enzyme-linked immunosorbent spot assay to measure serum-neutralizing antibodies against coxsackievirus B3.

Authors:  Lisheng Yang; Delei He; Min Tang; Zhiqun Li; Che Liu; Longfa Xu; Yixin Chen; Hailian Du; Qinjian Zhao; Jun Zhang; Tong Cheng; Ningshao Xia
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

2.  A strain-specific epitope of enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody.

Authors:  Hyunwook Lee; Javier O Cifuente; Robert E Ashley; James F Conway; Alexander M Makhov; Yoshio Tano; Hiroyuki Shimizu; Yorihiro Nishimura; Susan Hafenstein
Journal:  J Virol       Date:  2013-08-14       Impact factor: 5.103

3.  Development and evaluation of a pseudovirus-luciferase assay for rapid and quantitative detection of neutralizing antibodies against enterovirus 71.

Authors:  Xing Wu; Qunying Mao; Xin Yao; Pan Chen; Xiangmei Chen; Jie Shao; Fan Gao; Xiang Yu; Fengcai Zhu; Rongcheng Li; Wenhui Li; Zhenglun Liang; Junzhi Wang; Fengmin Lu
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

4.  Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2.

Authors:  Xiaojun Li; Peihu Fan; Jun Jin; Weiheng Su; Dong An; Lin Xu; Shiyang Sun; Yan Zhang; Xiangyu Meng; Feng Gao; Wei Kong; Chunlai Jiang
Journal:  Virol J       Date:  2013-08-06       Impact factor: 4.099

5.  Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine.

Authors:  Shi-Hsia Hwa; Yock Ann Lee; Joseph N Brewoo; Charalambos D Partidos; Jorge E Osorio; Joseph D Santangelo
Journal:  PLoS Negl Trop Dis       Date:  2013-11-07

6.  The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children.

Authors:  Qunying Mao; Tong Cheng; Fengcai Zhu; Jingxin Li; Yiping Wang; Yanping Li; Fan Gao; Lisheng Yang; Xin Yao; Jie Shao; Ningshao Xia; Zhenglun Liang; Junzhi Wang
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

7.  Antigenic and genetic diversity of human enterovirus 71 from 2009 to 2012, Taiwan.

Authors:  Yuan-Pin Huang; Tsuey-Li Lin; Ting-Han Lin; Ho-Sheng Wu
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

8.  Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay.

Authors:  Huafei Zhang; Dong An; Wei Liu; Qunying Mao; Jun Jin; Lin Xu; Shiyang Sun; Liping Jiang; Xiaojun Li; Jie Shao; Hongxia Ma; Xueyong Huang; Shijie Guo; Haiying Chen; Tong Cheng; Lisheng Yang; Weiheng Su; Wei Kong; Zhenglun Liang; Chunlai Jiang
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

9.  A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.

Authors:  Tanja K Kiener; Qiang Jia; Tao Meng; Vincent Tak Kwong Chow; Jimmy Kwang
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29

10.  Mapping Enterovirus A71 Antigenic Determinants from Viral Evolution.

Authors:  Sheng-Wen Huang; Ching-Hui Tai; Judith M Fonville; Chin-Hui Lin; Shih-Min Wang; Ching-Chung Liu; Ih-Jen Su; Derek J Smith; Jen-Ren Wang
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.